A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Members of our community are speaking up to make their voices heard and educate the public on the consequences of NIH cuts. But despite these efforts and those of advocates nationwide, sequestration will remain in effect until Congress repeals it.
Drs. Rudolph Leibel and Michael Rosenbaum are members of a multi-center collaboration that plans to test competing hypotheses of obesity and weight gain.
High-risk pregnant women being recruited for a clinical trial that aims to give parents detailed information about genetic abnormalities found in utero.
Two Columbia faculty are part of a 61-member international research team that discovered 25 epilepsy-causing mutations in new and previously identified genes.